3 Things You Really Need to Know About Arena Pharmaceuticals, Inc. Q3 Results

Like many biotechs Arena Pharmaceuticals Inc NASDAQ ARIA 160 hasn t had a great year in 2016 so far Shares of the biopharmaceutical company are down more than 20 year to date Arena announced its third quarter results after the market closed on Monday Were there signs